Cancer therapy evaluation program (http://ctep.info.nih.gov/)

被引：0
|
作者：
Fukuda, H
机构：
来源：
JAPANESE JOURNAL OF CLINICAL ONCOLOGY | 2000年 / 30卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：115 / 115
页数：1
相关论文
共 50 条
  • [41] Phase I Study Combining Ibrutinib with Rituximab, Ifosfamide, Carboplatin, and Etoposide (R-ICE) in Patients with Relapsed or Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL): NCI-Cancer Therapeutics Evaluation Program (CTEP) #9588
    Sauter, Craig S.
    Verwys, Stephanie L.
    McCall, Susan J.
    Miller, Shoshana T.
    Courtien, Amanda I.
    Schoder, Heiko
    Harris, Pamela
    Matasar, Matthew J.
    Younes, Anas
    Moskowitz, Craig H.
    BLOOD, 2016, 128 (22)
  • [42] Development and Evaluation of a Self-Care Program Based on Art Therapy for Mothers Caring for Hospitalized Children with Childhood Cancer: A Pilot Study
    Hong, Sungsil
    Jung, Jin
    Ahn, Jeonghee
    ASIAN ONCOLOGY NURSING, 2022, 22 (02) : 74 - 83
  • [43] Effect of Renal Dysfunction on Toxicity in Three Decades of Cancer Therapy Evaluation Program-Sponsored Single-Agent Phase I Studies
    Beumer, Jan H.
    Ding, Fei
    Tawbi, Hussein
    Lin, Yan
    Viluh, Diana
    Chatterjee, Indrani
    Rinker, Matthew
    Chow, Selina L.
    Ivy, S. Percy
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02) : 110 - +
  • [44] Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute
    Chihara, Dai
    Huang, Erich P.
    Finnigan, Shanda R.
    Cordes, Lisa M.
    Skorupan, Nebojsa
    Fukuda, Yoko
    Rubinstein, Larry, V
    Ivy, S. Percy
    Doroshow, James H.
    Nastoupil, Loretta J.
    Flowers, Christopher R.
    Takebe, Naoko
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (17) : 1949 - +
  • [45] Assessment of Cancer Therapy Evaluation Program Advocacy and Inclusion Rates of People Living With HIV in Anti-PD1/PDL1 Clinical Trials
    Reuss, Joshua E.
    Stern, Diana
    Foster, Jared C.
    Ramaswami, Ramya
    Lurain, Kathryn
    Chen, Helen X.
    Streicher, Howard
    Kem, Ravie
    Little, Richard F.
    Sharon, Elad
    JAMA NETWORK OPEN, 2020, 3 (12) : E2027110
  • [46] Identification of high-risk drugs related to chemotherapy-induced peripheral neuropathy in Cancer Therapy Evaluation Program-sponsored phase I trials
    Kishimoto, Shun
    Oshima, Nobu
    Rinker, Matthew
    Krishna, Murali C.
    Takebe, Naoko
    EUROPEAN JOURNAL OF CANCER, 2019, 115 : 111 - 119
  • [47] Bone Fracture Incidence After Androgen Deprivation Therapy-Investigational Agents: Results From Cancer Therapy Evaluation Program-Sponsored Early Phase Clinical Trials 2006-2013
    Myint, Zin W.
    Kunos, Charles A.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [48] Evaluation of the Sensitivity to Endocrine Therapy Index (SET2,3) in Early Male Breast Cancer: Results from an analysis in the EORTC 10085/TBCRC/BIG/NCTN International Male Breast Cancer Program
    Zakon, Danielle B.
    Poncet, Coralie
    Cardoso, Fatima
    Anouk, Neven
    Valero, Vicente
    Aebi, Stefan
    Benstead, Kim
    Bogler, Oliver
    Dal Lago, Lissandra
    Fraser, Judith
    Caballero, Carmela
    Hedenfalk, Ingrid A.
    Korde, Larissa A.
    Linderholm, Barbro
    Martens, John W. M.
    Middleton, Lavinia P.
    Murray, Melissa
    Kelly, Catherine M.
    Nilsson, Cecilia
    Nowaczyk, Monika
    Peeters, Stephanie
    Beauvois, Melanie
    Porter, Peggy
    Schroder, Carolien P.
    Rubio, Isabel T.
    Ruddy, Kathryn
    van Asperen, Christi
    Van Den Weyngaert, Danielle
    van Deurzen, Carolien H. M.
    van Leeuwen-Stok, Elise
    Vermeij, Joanna M.
    Bartlett, John M. S.
    Wolff, Antonio C.
    Giordano, Sharon H.
    Symmans, W. Fraser
    CANCER RESEARCH, 2023, 83 (05)
  • [49] [1,2-BIS(2-HYDROXYPHENYL)ETHYLENEDIAMINE]DICHLOROPLATINUM(II), A NEW COMPOUND FOR THE THERAPY OF OVARIAN-CANCER .3. DETAILED EVALUATION OF THE ANTITUMOR-ACTIVITY OF THE ENANTIOMERIC COMPLEXES ON THE HUMAN NIH-OVCAR-3 OVARIAN-CANCER CELL-LINE
    BERNHARDT, G
    GUST, R
    REILE, H
    VOMORDE, HD
    MULLER, R
    KELLER, C
    SPRUSS, T
    SCHONENBERGER, H
    BURGEMEISTER, T
    MANNSCHRECK, A
    RANGE, KJ
    KLEMENT, U
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1992, 118 (03) : 209 - 215
  • [50] Self-Study Program IV: Nuclear Medicine Oncology (2000)Bone Cancer Therapy - E.B. Silberstein; Radioimmunotherapy - G.L. DeNardo, S.J. DeNardo (eds). Society of Nuclear Medicine, Reston, VA, USA. ISBN 0-932004-63-6. http://servicecenter.snm.org. Price: US $ 15,- (member snm), US $ 20,- (nonmember snm).
    J. Bomanji
    S. Chhaya
    European Journal of Nuclear Medicine, 2001, 28 (6) : 782 - 782
12345